Stock Ratings / Health Care / CODX / earnings

ICCM (46) XAIR (42) AMIX (37) NVNO (50) ⌘ Pro Terminal →

Co-Diagnostics Inc. (CODX) Next Earnings Date & Expected ±12.5% Move

Q: When is CODX's next earnings date?

Based on SEC filing cadence, Co-Diagnostics Inc. (CODX)'s next quarterly reporting window is estimated around Dec 30, 2026.

Q: How much is CODX stock expected to move on earnings?

Volatility modeling currently projects a ±12.5% event move for CODX, spanning a range between $1 and $0.45.

$0.40 -10.49% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)

Co-Diagnostics Inc. (CODX) carries a Roarable Rating of D- (Sell) with 37/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D- • RED ALERT Cap $3.5M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERRED ALERT • D-

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- · Rk D-

Each axis scored 0–20

12M PRICE TARGET CONE-10% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for CODX)Realized 20D OHLCV Swing Band: ±12.5%

NEXT EST. WINDOW: Dec 30, 2026 (~58 DAYS)

Historical OHLCV Volatility ±12.5% Swing Band

±$0.05 Expected Swing

MODEL EARNINGS SETUP GAUGE

CODX Quantitative Pre-Earnings Setup: 37/100

Trailing EPS: $4.25 • YoY Revenue Growth: -65%

Model Bullish Setup (37/100)Model Risk Weight (63/100)

Derived deterministically from RQD cash-flow quality, SEC accrual safety, and institutional flow (not a community poll).

LOG YOUR PERSONAL PRE-EARNINGS STANCE (SAVED LOCALLY IN BROWSER):

Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence

Period	Filed	Revenue	Net Profit	Free Cash Flow	Gross Margin
FY 2025	2025-12-31	$622.5K	-$47.0M	-$29.8M	64.3%
FY 2024	2024-12-31	$3.9M	-$38.0M	-$29.9M	74.5%
FY 2023	2023-12-31	$6.8M	-$35.3M	-$22.1M	64.3%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring CODX)

✓Walkthrough of CODX's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

CODX // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -74.19%⚡ TESTING RESISTANCE

2026-10-30O $0.40H $0.40L $0.37C $0.40VOL 233.3K

RES: $0.65SUP: $-2.52SMA50: $0.98SMA200: $2.20

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

CODX Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 CODX Butterfly Map → + Track CODX →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. -65.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on CODX today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for CODX. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for CODX today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (CODX)

Health Care Rank #769 of 1016 ⚔️ ICCM vs CODX Full Matrix →

1. Head-to-Head Health Care Peer Comparison (CODX vs. ICCM, XAIR, AMIX, NVNO)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Co-Diagnostics Inc. (CODX) ranks #769 by composite RQD confidence (37/100, grade D-) and #970 by equity capitalization ($3.5M). Within this direct 5-issuer industry benchmark cohort, XAIR leads on earnings valuation at 112.1x trailing P/E, while CODX leads on capital efficiency and profitability with -35.0% ROIC and 64.3% gross margin. NVNO currently holds the highest overall quantitative score in the immediate peer group at 50/100 (D) compared with CODX at 37/100 (D-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
CODX ACTIVE Co-Diagnostics Inc.	D-	37/100	—	64.3%	-35.0%	-10.49%	$3.5M	Benchmark Subject
ICCM IceCure Medical Ltd.	D	46/100	—	36.3%	-35.0%	-2.13%	$3.3M	/iccm-vs-codx →
XAIR Beyond Air Inc.	D-	42/100	112.1x	3.3%	-35.0%	-2.12%	$3.8M	/xair-vs-codx →
AMIX Autonomix Medical Inc.	D-	37/100	—	—	-35.0%	-5.12%	$4.0M	/amix-vs-codx →
NVNO enVVeno Medical Corporation	D	50/100	—	—	-35.0%	+4.08%	$4.9M	/nvno-vs-codx →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001692415

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Co-Diagnostics Inc. (CODX) reported GAAP revenue of $622.5K (-84.1% vs. FY2024 revenue of $3.9M , and -90.9% cumulative change since FY2023) , GAAP net income of -$47.0M, operating cash flow of -$29.1M, and free cash flow of -$29.8M (+0.2% YoY). On the balance sheet, CODX closed FY2025 with $24.7M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 3/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$622.5K	-$47.0M	-$29.1M	-$29.8M	$24.7M	—
FY2024 (FY)	2024-12-31	$3.9M	-$38.0M	-$29.2M	-$29.9M	$63.6M	—
FY2023 (FY)	2023-12-31	$6.8M	-$35.3M	-$22.1M	-$22.1M	—	—

3. CODX Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is CODX stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Co-Diagnostics Inc. (NASDAQ: CODX) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 37/100 at a spot price of $0.40 (-10.49% 1D, market cap $3.5M). Pillar breakdown: Fundamental Cash Engine 7/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, CODX ranks #769 in composite RQD confidence.

How does CODX compare to ICCM and XAIR in the Health Care sector?

Within the Health Care sector (Medical/Dental Instruments), CODX carries a Roarable D- (37/100 RQD), trailing P/E of N/A, gross margin of 64.3%, and ROIC of -35.0%. By comparison, ICCM (IceCure Medical Ltd.) holds a D grade (46/100 RQD, P/E N/A, ROIC -35.0%, cap $3.3M) and XAIR (Beyond Air Inc.) posts a D- grade (42/100 RQD, P/E 112.1x, ROIC -35.0%, cap $3.8M). Among the 5-stock peer group, XAIR leads on earnings multiple (112.1x) while CODX leads on capital efficiency (-35.0% ROIC).

What are the biggest fundamental strengths and SEC risk factors for CODX?

Per CODX's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001692415), Co-Diagnostics Inc. generated $622.5K in revenue (-84.1% YoY), -$47.0M in net income, and -$29.8M in free cash flow against $24.7M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is CODX trading relative to its 50-day, 200-day, and 52-week technical levels?

CODX last traded at $0.40 (-10.49% on volume of 553,918 shares), positioning the stock -59.18% below its 50-day simple moving average ($0.98) and -81.82% below its 200-day simple moving average ($2.20). Across its 52-week range of $0.37 to $13.80, CODX sits at the 0.2% percentile with a 14-day RSI of 19.1 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($1.00 to $0.45).

CODX Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

When is CODX's next earnings date?

Based on SEC filing cadence, Co-Diagnostics Inc. (CODX)'s next quarterly reporting window is estimated around Dec 30, 2026.

How much is CODX stock expected to move on earnings?

Volatility modeling currently projects a ±12.5% event move for CODX, spanning a range between $1 and $0.45.

Direct Sub-Reports: CODX RQD Cockpit CODX 12M Forecast CODX Earnings & Move CODX Dividends & DRIP CODX Insiders & 13F CODX Whale Options CODX Profit Sankey CODX News & Why